Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis

OBJECTIVES: To evaluate maintenance of response while reducing intravenous abatacept dose from ∼10 mg/kg to ∼5 mg/kg in patients with early rheumatoid arthritis (RA) who achieved disease activity score (DAS)28 (erythrocyte sedimentation rate, ESR) <2.6. METHODS: This 1-year, multinational, random...

Descripción completa

Detalles Bibliográficos
Autores principales: Westhovens, Rene, Robles, Manuel, Ximenes, Antonio Carlos, Wollenhaupt, Jurgen, Durez, Patrick, Gomez-Reino, Juan, Grassi, Walter, Haraoui, Boulos, Shergy, William, Park, Sung-Hwan, Genant, Harry, Peterfy, Charles, Becker, Jean-Claude, Murthy, Bindu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345907/
https://www.ncbi.nlm.nih.gov/pubmed/25550337
http://dx.doi.org/10.1136/annrheumdis-2014-206149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345907/
https://www.ncbi.nlm.nih.gov/pubmed/25550337
http://dx.doi.org/10.1136/annrheumdis-2014-206149

Ejemplares similares